FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,048 letters match. Newest first.
-
DrugsNorthern VA Compounders PLLC, dba Akina Pharmacy
FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.
High risk -
DevicesRoyal Philips
FDA warns Royal Philips over unvalidated supplier molding for CT monitor cable and unreported device corrections at Suzhou plant.
High risk -
FoodLa Sucursal Produce Inc.
La Sucursal Produce lacked FSVP for imported husk tomato, green onion, and peas and failed to register its Los Angeles facility.
Medium -
FoodEuro USA Inc
Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.
High risk -
FoodAppleton City Feed Service LLC
FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.
High risk -
FoodNew India Bazar, Inc.
FDA cites New India Bazar for missing FSVP and allergen hazard analysis after MAGGI noodle recall.
High risk -
FoodThuan Thien Producing Trading Limited Company
FDA warns Thuan Thien that its frozen juices lack validated 5-log pathogen reduction and coconut juice treatment is inadequate.
High risk -
DevicesBeckman Coulter Inc.
FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.
High risk -
FoodZoet Poultry, Inc.
Zoet Poultry's shell egg farm lacked an implemented Salmonella Enteritidis prevention plan and required environmental testing.
High risk -
DrugsDermal Source, Inc.
FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.
High risk -
DrugsSeeNext Venture, Ltd.
FDA warns SeeNext Venture over unapproved, misbranded NumbSkin lidocaine creams sold online.
High risk -
DrugsTKTX Company
TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.
High risk -
DrugsHigley Industries, Inc.
FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.
High risk -
DevicesReNovo, Inc. DBA Provision Device Reprocessing Solutions
ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.
High risk -
DevicesSol-Millennium Medical, Inc.
Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.
High risk -
FoodSen Up Huat Seafood Trading Sdn Bhd
FDA warns Malaysian seafood processor Sen Up Huat over inadequate histamine controls in its seafood safety plan for bonito and other fish.
High risk -
BiologicsHuman Microbes
FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.
High risk -
DevicesNobles Medical Technology II, Inc.
FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.
High risk -
DevicesExactech, Inc.
Exactech shoulder and hip implants had quality-system and medical-device reporting failures, including a late GXL liner wear report.
High risk -
DrugsNative Salts LLC
FDA warns Native Salts LLC over unapproved, misbranded ammonia smelling-salt stimulant sold as 'N, Native Salts'.
High risk -
FoodDream Wholesale, Inc
Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.
High risk -
DrugsBell International Laboratories, Inc.
Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.
High risk -
FoodBarsotti Juice Company, Inc.
FDA warned Barsotti Juice that its organic carrot juice safety plan does not control Clostridium botulinum.
High risk -
FoodAgila Corporation dba Woody’s Pet Food Deli
FDA found Salmonella and Listeria in Woody's raw pet food and an unapproved additive in use.
High risk -
DevicesFresenius Kabi AG
FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.
High risk -
FoodTrang Thuy Seafood Co., LTD
FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.
High risk -
FoodGilster-Mary Lee Corporation
Gilster-Mary Lee's recalled HyVee skillet meal was misbranded because its label did not declare milk, a major allergen.
High risk -
FoodHealthtex Distributors, Inc.
FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.
Medium -
FoodPt Dua Kelinci
FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.
High risk -
DrugsSynthetix Inc. DBA Helix Chemical Supply
FDA says Synthetix Inc., doing business as Helix Chemical Supply, sold unapproved and misbranded Semaglutide and Tirzepatide drugs online.
High risk -
DrugsMadhu Instruments Private Limited
FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.
High risk -
BiologicsBarkey GmbH & Co. KG
FDA warns Barkey over unapproved plasmatherm V blood thawing device and missing design risk analysis.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
FoodCurtis Jacquot dba Pacific BioLogic Co.
Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.
High risk -
FoodIowa Egg Company Inc.
Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.
High risk -
FoodIndian Groceries and Spices, Inc.
FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.
Medium -
FoodPerfection Bakeries Inc., dba Aunt Millie’s Bakeries
Perfection Bakeries, dba Aunt Millie’s, recalled Our Family white hot dog buns because the label did not declare sesame.
High risk -
DrugsEhy Holdings, LLC
FDA warned Ehy Holdings over unupdated drug listings for nicotine patches and creams, calling products misbranded.
Low -
DrugsLes Importations Herbasanté Inc.
Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.
High risk -
FoodInmar Supply Chain Solutions, LLC
FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
FoodGrace Supply Inc.
Grace Supply lacked required foreign supplier verification for most imported foods and adequate Salmonella verification for shredded coconut.
High risk -
FoodJJR Global Inc.
FDA warns JJR Global over missing FSVP for imported chutneys and other foods.
Medium -
FoodMartin Farm, Konrad Martin
Nappanee dairy farm used enrofloxacin and ceftiofur in calves contrary to labeling and kept incomplete treatment records.
High risk -
FoodReConserve Inc.
FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.
High risk -
DevicesDr. Joel Kaplan Inc.
FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.
High risk -
AnimalSamuel Rodriguez dba KiloKennelzz
KiloKennelzz marketed Green Monster, an unapproved injectable animal drug, online with claims to treat dog diseases.
High risk -
BiologicsMiMedx Group, Inc.
FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.
High risk -
DrugsJeffrey W. Taub, M.D./Children's Hospital of Michigan
FDA warns Detroit investigator over pediatric drug trial protocol deviations and lapsed IRB approval.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium